Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMC Pulmonary Medicine|May 3, 2022
Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesotheliomaDuneesha De Fonseka, David T Arnold, Anna J Morley, et al.
Frontiers in Medicine|October 3, 2022
A multidisciplinary approach to the diagnosis of antisynthetase syndromeMatthew Wells, Sughra Alawi, Kyaing Yi Mon Thin, et al.
Annals of the American Thoracic Society|March 22, 2017
Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy ProjectNatalia Popowicz, Oliver Bintcliffe, Duneesha De Fonseka, et al.
BMJ Open Respiratory Research|May 21, 2020
British Thoracic Society Training Standards for Thoracic Ultrasound (TUS)Andrew E Stanton, Anthony Edey, Matthew Evison, et al.
Lung Cancer (Amsterdam, Netherlands)|July 19, 2025
Serum mesothelin as a response biomarker in pleural mesotheliomaGeraldine A Lynch, Jenny Symonds, Anna Morley, et al.
Respirology (Carlton, Vic.)|January 4, 2012
Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumoniaTamera J Corte, Stephen J Wort, Peter S MacDonald, et al.
The Lancet. Respiratory Medicine|July 15, 2015
Spontaneous pneumothorax: time to rethink management?Oliver J Bintcliffe, Rob J Hallifax, Anthony Edey, et al.
Trials|August 31, 2018
Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trialDuneesha de Fonseka, Anna Morley, Louise Stadon, et al.
BMJ Open Respiratory Research|March 14, 2018
BTS guideline for the investigation and management of malignant pleural mesotheliomaIan Woolhouse, Lesley Bishop, Liz Darlison, et al.
The European Respiratory Journal|October 9, 2020
European Respiratory Society statement on thoracic ultrasoundChristian B Laursen, Amelia Clive, Rob Hallifax, et al.
Pageof 3